MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on July 18, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on July 18, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on July 18, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on July 18, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on July 18, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on July 18, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on July 18, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF OTAGO on July 18, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Fotemustine plus dacarbazine for malignant melanoma.
Intrathecal dacarbazine treatment of leptomeningeal malignant melanoma.
Fotemustine plus dacarbazine in advanced stage III malignant melanoma.
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.
Tamoxifen in malignant melanoma.
[Systemic treatment of distant metastatic malignant melanoma].
Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis.
metastatic melanoma: a phase II study.
Targeted Therapies Compared to Dacarbazine for Treatment of BRAF(V600E) Metastatic Melanoma: A Cost-Effectiveness Analysis.
Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma.
Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma.
A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
Spontaneous pneumothorax with metastatic malignant melanoma.
Fotemustine--an advance in the treatment of metastatic malignant melanoma.
Metastatic malignant melanoma: computed tomography-guided 125I seed implantation treatment.
Metastatic malignant melanoma affecting stomach.
Bevacizumab plus ipilimumab in patients with metastatic melanoma.
Splenic lymphoma in a patient treated with interleukin-2 and dacarbazine for metastatic melanoma.
Metastatic malignant melanoma of the urinary bladder.
Survival rates of patients with metastatic malignant melanoma.
Treatment of malignant melanoma.
Local treatment of cutaneous and subcutaneous metastatic malignant melanoma with fotemustine.
Massive hemothorax due to metastatic malignant melanoma.
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.
Endocrine factors may affect the clinical course of malignant melanoma and the response to the treatment of this disease. The presence of estrogen rec...
1MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Fotemustine plus dacarbazine for malignant melanoma.
Intrathecal dacarbazine treatment of leptomeningeal malignant melanoma.
Fotemustine plus dacarbazine in advanced stage III malignant melanoma.
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.
Tamoxifen in malignant melanoma.
[Systemic treatment of distant metastatic malignant melanoma].
Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis.
metastatic melanoma: a phase II study.
Targeted Therapies Compared to Dacarbazine for Treatment of BRAF(V600E) Metastatic Melanoma: A Cost-Effectiveness Analysis.
Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms